NCT01068977 2017-05-19A Study of the Safety and Pharmacology of MetMAb (PRO143966), a Monovalent Antagonist Antibody to the Receptor C-Met, Administered Intravenously in Patients With Locally Advanced or Metastatic Solid TumorsGenentech, Inc.Phase 1 Completed44 enrolled